These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33424667)

  • 1. Two-Hour Tobacco Abstinence Has No Effect on Cognitive Control in Male Patients With Nicotine Dependence: An ERP Study.
    Xue Y; Zhou H; Jiang C; Liu X; Zhou Z; Wang J
    Front Psychiatry; 2020; 11():604684. PubMed ID: 33424667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Control Deficits in Alcohol Dependence Are a Trait- and State-Dependent Biomarker: An ERP Study.
    Liu X; Zhou H; Jiang C; Xue Y; Zhou Z; Wang J
    Front Psychiatry; 2020; 11():606891. PubMed ID: 33363489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7 mg nicotine patch fails to enhance P300 neural indices of cognitive control among nonsmokers.
    Evans DE; Jentink KG; Sutton SK; Van Rensburg KJ; Drobes DJ
    Pharmacol Biochem Behav; 2014 Nov; 126():77-82. PubMed ID: 25218552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-Hour Nicotine Withdrawal Improves Inhibitory Control Dysfunction in Male Smokers: Evidence from a Smoking-Cued Go/No-Go Task ERP Study.
    Hou L; Zhang J; Liu J; Chen C; Gao X; Chen L; Zhou Z; Zhou H
    Neuropsychiatr Dis Treat; 2024; 20():863-875. PubMed ID: 38645711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine deprivation influences P300 markers of cognitive control.
    Evans DE; Maxfield ND; Van Rensburg KJ; Oliver JA; Jentink KG; Drobes DJ
    Neuropsychopharmacology; 2013 Nov; 38(12):2525-31. PubMed ID: 23807239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Brain evoked potentials in patients with depression or anxiety].
    Zhu CY; Zheng Z; Qiu CJ; Zou K; Nie XJ; Feng Y; Wu RZ; Zhang W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):708-11. PubMed ID: 19764579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between P3a and P3b amplitudes and cognition in antipsychotic-naïve first-episode schizophrenia patients.
    Kruiper C; Fagerlund B; Nielsen MØ; Düring S; Jensen MH; Ebdrup BH; Glenthøj BY; Oranje B
    Psychol Med; 2019 Apr; 49(5):868-875. PubMed ID: 29914589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline-dependent modulating effects of nicotine on voluntary and involuntary attention measured with brain event-related P3 potentials.
    Knott V; Choueiry J; Dort H; Smith D; Impey D; de la Salle S; Philippe T
    Pharmacol Biochem Behav; 2014 Jul; 122():107-17. PubMed ID: 24690514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P3b amplitude as a signature of cognitive decline in the older population: An EEG study enhanced by Functional Source Separation.
    Porcaro C; Balsters JH; Mantini D; Robertson IH; Wenderoth N
    Neuroimage; 2019 Jan; 184():535-546. PubMed ID: 30248455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auditory P3a and P3b neural generators in schizophrenia: An adaptive sLORETA P300 localization approach.
    Bachiller A; Romero S; Molina V; Alonso JF; Mañanas MA; Poza J; Hornero R
    Schizophr Res; 2015 Dec; 169(1-3):318-325. PubMed ID: 26481687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic stimulation at acupoints relieves mental fatigue: An Event Related Potential (P300) study.
    Yang S; Qiao Y; Wang L; Hao P
    Technol Health Care; 2017 Jul; 25(S1):157-165. PubMed ID: 28582903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study.
    Mathalon DH; Ford JM; Pfefferbaum A
    Biol Psychiatry; 2000 Mar; 47(5):434-49. PubMed ID: 10704955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P300 amplitude and latency in autism spectrum disorder: a meta-analysis.
    Cui T; Wang PP; Liu S; Zhang X
    Eur Child Adolesc Psychiatry; 2017 Feb; 26(2):177-190. PubMed ID: 27299750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
    Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
    Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tobacco smoking on electroencephalographic, auditory evoked and event related potentials.
    Domino EF
    Brain Cogn; 2003 Oct; 53(1):66-74. PubMed ID: 14572504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of GAD1 genotype status on auditory attention and acute nicotine administration in healthy volunteers.
    Hadjis E; Hyde M; Choueiry J; Jaworska N; Nelson R; de la Salle S; Smith D; Aidelbaum R; Knott V
    Hum Psychopharmacol; 2019 Jan; 34(1):e2684. PubMed ID: 30488987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive processes in Parkinson's disease--an event-related potential analysis].
    Toda K
    Nihon Ronen Igakkai Zasshi; 1991 Nov; 28(6):801-10. PubMed ID: 1795443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intolerance for smoking abstinence among nicotine-deprived, treatment-seeking smokers.
    Germeroth LJ; Baker NL; Saladin ME
    Addict Behav; 2018 Sep; 84():13-19. PubMed ID: 29597136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study.
    McClure EA; Baker NL; Sonne SC; Ghitza UE; Tomko RL; Montgomery L; Babalonis S; Terry GE; Gray KM
    Drug Alcohol Depend; 2018 Nov; 192():59-66. PubMed ID: 30218864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.